iSpecimen Inc. (ISPC)
USD 1.18
(-4.45%)
USD 1.18
(-4.45%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -11.09 Million USD | -22.77% |
| 2022 | -9.04 Million USD | 9.74% |
| 2021 | -10.01 Million USD | -48.2% |
| 2020 | -6.75 Million USD | -42.98% |
| 2019 | -4.72 Million USD | 11.6% |
| 2018 | -5.34 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -2.1 Million USD | 27.33% |
| 2024 Q1 | -2.9 Million USD | 5.56% |
| 2023 Q4 | -3.07 Million USD | -45.56% |
| 2023 FY | -11.09 Million USD | -22.77% |
| 2023 Q3 | -2.11 Million USD | 39.4% |
| 2023 Q2 | -3.48 Million USD | -50.31% |
| 2023 Q1 | -2.31 Million USD | -29.2% |
| 2022 Q2 | -2.6 Million USD | -8.21% |
| 2022 Q1 | -2.4 Million USD | -17.49% |
| 2022 Q3 | -3.09 Million USD | -18.55% |
| 2022 FY | -9.04 Million USD | 9.74% |
| 2022 Q4 | -1.79 Million USD | 41.95% |
| 2021 Q2 | -1.39 Million USD | 64.81% |
| 2021 FY | -10.01 Million USD | -48.2% |
| 2021 Q1 | -3.96 Million USD | -148.72% |
| 2021 Q4 | -2.05 Million USD | -32.03% |
| 2021 Q3 | -1.55 Million USD | -11.33% |
| 2020 Q4 | -1.59 Million USD | -27.86% |
| 2020 FY | -6.75 Million USD | -42.98% |
| 2020 Q3 | -1.24 Million USD | -615.9% |
| 2020 Q2 | -174.09 Thousand USD | 89.37% |
| 2020 Q1 | -1.63 Million USD | -21.44% |
| 2019 FY | -4.72 Million USD | 11.6% |
| 2019 Q3 | -2.1 Million USD | 0.0% |
| 2019 Q4 | -1.34 Million USD | 35.95% |
| 2018 FY | -5.34 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | -88.48 Million USD | 87.456% |
| Applied DNA Sciences, Inc. | -9.94 Million USD | -11.586% |
| Aspira Women's Health Inc. | -16.69 Million USD | 33.496% |
| Biodesix, Inc. | -52.14 Million USD | 78.715% |
| BioNexus Gene Lab Corp. | -2.62 Million USD | -322.187% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -39.845% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -39.845% |
| Bionano Genomics, Inc. | -232.49 Million USD | 95.226% |
| CareDx, Inc | -190.28 Million USD | 94.167% |
| Check-Cap Ltd. | -17.56 Million USD | 36.82% |
| Castle Biosciences, Inc. | -57.46 Million USD | 80.685% |
| DarioHealth Corp. | -59.42 Million USD | 81.322% |
| Exact Sciences Corporation | -204.14 Million USD | 94.563% |
| Fulgent Genetics, Inc. | -167.82 Million USD | 93.386% |
| Guardant Health, Inc. | -479.44 Million USD | 97.685% |
| ICON Public Limited Company | 612.33 Million USD | 101.813% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | 101.313% |
| Illumina, Inc. | -1.16 Billion USD | 99.044% |
| Intelligent Bio Solutions Inc. | -10.15 Million USD | -9.282% |
| Standard BioTools Inc. | -74.65 Million USD | 85.132% |
| MDxHealth SA | -43.1 Million USD | 74.247% |
| 23andMe Holding Co. | -666.7 Million USD | 98.335% |
| Medpace Holdings, Inc. | 282.81 Million USD | 103.925% |
| Myriad Genetics, Inc. | -112 Million USD | 90.09% |
| Mainz Biomed B.V. | -26.29 Million USD | 57.79% |
| ENDRA Life Sciences Inc. | -10.06 Million USD | -10.33% |
| NeoGenomics, Inc. | -87.96 Million USD | 87.382% |
| Neogen Corporation | -9.42 Million USD | -17.816% |
| Inotiv, Inc. | -105.14 Million USD | 89.443% |
| Natera, Inc. | -434.8 Million USD | 97.447% |
| OpGen, Inc. | -32.66 Million USD | 66.024% |
| OPKO Health, Inc. | -188.86 Million USD | 94.123% |
| Psychemedics Corporation | -4.15 Million USD | -167.2% |
| Prenetics Global Limited | -62.72 Million USD | 82.304% |
| Prenetics Global Limited | -62.72 Million USD | 82.304% |
| Precipio, Inc. | -5.85 Million USD | -89.638% |
| Personalis, Inc. | -108.29 Million USD | 89.751% |
| RadNet, Inc. | 3.04 Million USD | 464.635% |
| Sera Prognostics, Inc. | -36.24 Million USD | 69.374% |
| Sotera Health Company | 51.37 Million USD | 121.604% |
| Neuronetics, Inc. | -30.18 Million USD | 63.233% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -617.021% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -617.021% |
| Trinity Biotech plc | -24.01 Million USD | 53.787% |
| T2 Biosystems, Inc. | -50.07 Million USD | 77.835% |
| Twist Bioscience Corporation | -208.72 Million USD | 94.682% |
| Exagen Inc. | -23.68 Million USD | 53.145% |